# CORRESP — Elicio Therapeutics, Inc.  (ELTX)  (CIK 0001601485)

> <strong>Elicio Therapeutics, Inc.  (ELTX)  (CIK 0001601485) → SEC staff</strong> · filed 2025-12-01 · ticker ELTX · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001601485-25-000128
- **Form:** CORRESP
- **Filer:** Elicio Therapeutics, Inc.  (ELTX)  (CIK 0001601485)
- **CIK:** 0001601485
- **Ticker:** ELTX
- **Filed:** 2025-12-01
- **SIC industry:** 2834
- **HQ:** Boston, MA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1601485/000160148525000128/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1601485&type=UPLOAD&dateb=&owner=include&count=40

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Elicio Therapeutics, Inc.  (ELTX)  (CIK 0001601485) (CIK 0001601485), filed 2025-12-01, accession 0001601485-25-000128. Retrieved via MORVS 2026-11-12 from https://api.morvs.ai/comment-letter/0001601485-25-000128.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*